Microneedle Measles Vaccine Patch Could Boost Alabama's Public Health Efforts

Why it matters locally: The development of a microneedle patch for measles vaccination has significant implications for Alabama, particularly in improving vaccination rates and accessibility across the state. With a population of over 5 million, ensuring widespread measles immunity is crucial to prevent outbreaks. The patch's potential to eliminate the need for trained medical personnel for administration could be especially beneficial in rural or underserved areas of Alabama, where access to healthcare providers may be limited. Improved vaccine stability could reduce wastage and make distribution logistics to these areas easier. This ease of use could directly impact vaccination rates.

---

Atlanta, GA – A collaborative effort between the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC) is focused on creating a microneedle patch designed to deliver measles vaccines. The research team hopes the new technology will offer several advantages over traditional injection methods. The patch utilizes microscopic needles, imperceptible to the naked eye, to administer the vaccine under the skin. This method could potentially eliminate the need for trained medical personnel to administer the shots. The developers hope the patch format will make measles vaccination more accessible in locations with limited resources. While details on the patch's composition and clinical trial timelines remain undisclosed, the project signifies ongoing efforts to improve vaccine delivery systems and combat vaccine-preventable diseases like measles. The project aims to create a more stable, easy-to-administer alternative to traditionally refrigerated and injected vaccines. If successful at scale, this could offer wider access to vaccination which could reduce cases and potential spread of the disease.